Maciej Wieczorek, at the Impact CEE conference, talking about financing the Polish biotechnology industry and its future

Maciej Wieczorek, CEO was a guest of the Impact CEE conference . A series of such meetings is attended by representatives of national research institutes, Polish and international companies, the public administration and representatives of start-ups. The subject of the first debate was the biotech industry, it took place on 19 February 20118 at the seat of the Warsaw Stock Exchange.

Maciej Wieczorek: The biotech industry is quite specific. It is very cost-intensive, the return on investment in the product is possible after a long period of time, and at the same time it is very profitable. Co-funding of the industry, including with funds from the capital market is incredibly important and makes it possible to i.a. increase the scientific level of the developed projects.